VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
LFMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LFMDLifeMD, Inc.
$1.70$82M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLFMDCash Flow

LifeMD, Inc. (LFMD) Cash Flow Statement

15Y historyFree accessUpdated daily

Free cash flow swung to negative $10.5M (-22.2% margin) in 2026Q2 from $11.5M in 2025Q2, and with $776.6K of quarterly dividends and no buybacks, cash conversion appears unstable and warrants further investigation.

Income StatementBalance SheetCash FlowRatios

LFMD Cash Flow Statement

Annual statement

LFMD Cash Flow Statement

LifeMD, Inc. (LFMD) cash flow statement — 15-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Cash from Operations-10.71M8.28M17.51M8.82M-22.94M-33.09M-12.13M251.41K-905.52K-817.22K-407.91K-295.12K33.44K-259.07K-229.73K-17.69K
Operating CF Margin %-4.27%8.24%5.78%-19.27%-35.62%-32.53%2.02%-10.88%-16.17%-7.79%-24.21%4.68%-32.05%-34.1%-2.38%
Operating CF Growth %-1120.26%-52.72%98.56%138.46%30.68%-172.72%-4925.47%127.76%-10.81%-100.34%-38.22%-982.57%112.91%-12.78%-1198.91%-
Net Income-21.92M15.62M-18.73M-20.6M-45.02M-61.32M-60.52M-3.53M-1.36M-1.21M-1.22M-159.23K-460.49K-268.26K-445.65K-502.93K
Depreciation & Amortization8.05M7.31M9.49M6.6M3.77M868.76K397.76K335.61K195.78K91.56K33.72K43.75K56.98K56.97K56.97K56.69K
Stock-Based Compensation6.58M10.5M12.23M12.49M13.73M12.07M18.66M733.22K273.57K162.74K587.99K142.3K125.5K105K84K400K
Deferred Taxes0000354K0914.86K66K4K-90.28K37.42K-13.2K-17.2K-17.2K-17.2K-17.2K
Other Non-Cash Items-17.65M-17.29M1.87M5.42M5.78M6.17M19.63M578.61K237.2K918.01K33.72K-127.26K80.5K48.75K122.31K-17.2K
Working Capital Changes-2.72M-7.85M12.65M4.91M-1.55M9.13M8.8M2.07M-255.97K-693.28K122.54K-181.48K328.65K-184.34K-30.16K45.75K
Change in Receivables-11.22M1.15M-2.94M-2.44M-2.19M17.7K-550.97K1.6K29.14K95.09K-361.44K-139.47K62.51K-27.79K-13.33K43.97K
Change in Inventory-6.31M303.24K675.67K764.33K-2.18M-409.82K-314.2K72.56K-341.36K-546.89K-99.22K-20.04K45.19K-22.82K-4.58K46.2K
Change in Payables23.29M3.24M4.92M978.06K1.25M-893.96K8.93M1.89M6.34K-227.23K585.45K-21.97K88.96K-1.73K-12.24K-134.41K
Cash from Investing11.88M6.91M-11.54M-8.73M-13.91M-3.4M-798.14K-100K141.44K63.38K219.89K127.26K0000
Capital Expenditures-4.54M-1.87M-1.49M-203.81K-366.63K-247.37K-398.14K0-100K0000000
CapEx % of Revenue2.4%0.96%0.7%0.13%0.31%0.27%1.07%-1.2%-------
Acquisitions0000-1.01M0-400K-100K241.44K63.38K219.89K00000
Investments----------------
Other Investing16.43M8.78M-10.05M-8.53M-12.53M-3.15M0-100K290K00127.26K0000
Cash from Financing-3.04M-13.41M-4.12M29.1M-528.2K68.64M21M775.12K802.79K776.03K357.49K325.35K-113K315.2K295.15K51.19K
Debt Issued (Net)0-18.72M-327.6K16.67M2.74M-530.82K93.19K798.28K642.44K116.06K131.4K158K-13K40.2K-50.73K-142.31K
Equity Issued (Net)80.52K9.19M016.2M069.33M20.13M350K0596.6K-23.8K-10.8K0175K345.88K193.5K
Dividends Paid-3.11M-3.11M-3.11M-3.11M-3.11M-871.48K-1.29M0000-10.8K0000
Share Repurchases000000000-76.65K-87.05K-10.8K0000
Other Financing-12K-773.66K-684.83K-667.63K-159.2K707.36K2.07M-373.15K160.35K63.38K249.89K188.95K-100K100K00
Net Change in Cash-1.86M1.78M1.86M29.19M-37.37M32.15M8.07M926.53K38.71K-41.18K-50.42K157.49K-79.56K56.13K65.43K33.5K
Free Cash Flow-16.05M-1.24M5.98M86.95K-35.83M-36.49M-12.53M251.41K-1.01M-817.22K-407.91K-295.12K33.44K-259.07K-229.73K-17.69K
FCF Margin %-8.5%-0.64%2.81%0.06%-30.1%-39.29%-33.6%2.02%-12.08%-16.17%-7.79%-24.21%4.68%-32.05%-34.1%-2.38%
FCF Growth %-194.56%-120.72%6774.08%100.24%1.81%-191.21%-5083.83%125%-23.04%-100.34%-38.22%-982.57%112.91%-12.78%-1198.91%-
FCF per Share-0.33-0.030.150.00-1.16-1.35-0.880.03-0.11-0.09-0.06-0.050.01-0.04-0.04-0.00
FCF Conversion (FCF/Net Income)0.73x-1.17x-0.93x-0.43x0.50x0.54x0.21x-0.08x0.73x0.68x0.37x4.76x-0.07x0.97x0.52x0.04x
Interest Paid0000189K435.05K0000000000
Taxes Paid0000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Operating cash flow reversal persists

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Net Losses Mask Erratic Operating Cash

Based on LifeMD's reported quarterly figures, operating cash flow swung from $8.6M in 2025Q2 to negative $6.9M in 2026Q2, producing an OCF-to-net-income ratio that lacks a stable meaning across the ten quarters examined.

The ratio is distorted by the sign changes in net income, so 2024Q4's ratio of -14.76 and 2025Q1's ratio of 2.22 reflect noise rather than earnings quality. The more informative observation is that operating cash flow turned negative in the latest quarter while net losses also widened, suggesting the business is not currently converting revenue into cash. Investors should monitor whether the 2026Q2 outflow reflects working capital timing or a sustained operating deficit.

Free Cash Flow Turns Sharply Negative

According to reported cash flow statements, LifeMD's free cash flow fell to negative $10.5M in 2026Q2, a -22.2% margin, after a peak of $11.5M in 2025Q2 when the margin reached 18.5%.

Free cash flow has oscillated rather than trended, with the margin ranging from roughly -22% to +18% over the period. The latest quarter's deterioration coincides with contracting revenue, which suggests the swings are driven by operating volatility rather than a stable cash generation base. The pattern warrants further investigation into whether the 2025Q2 peak was representative or an outlier.

Working Capital Swings Drive Cash Volatility

Based on LifeMD's reported figures, working capital changes ranged from a $6.9M inflow in 2024Q3 to a $5.7M inflow in 2026Q1 and a $2.9M outflow in 2026Q2, indicating that timing effects are a material driver of quarterly cash flow.

The magnitude of working capital movements is comparable to the operating cash flow itself in several quarters, implying that reported operating cash generation is highly sensitive to receivable, inventory, and payable timing. Quarters with large inflows may reverse, so the underlying cash earnings power is likely lower than any single quarter suggests. Investors should monitor whether working capital reversals continue to offset or mask operating performance.

Dividend Outflows Exceed Cash Generation

As reported in financial statements, LifeMD paid $776.6K in dividends in every quarter examined and recorded no buybacks or acquisitions, so distributions were funded from cash flows that were negative in several periods.

The fixed quarterly dividend is small relative to the company's cash flow volatility, yet it is paid consistently even in quarters with negative free cash flow of -$10.5M. This suggests distributions are not currently covered by internally generated free cash flow over the period. The absence of buybacks and acquisitions indicates capital is being preserved rather than actively deployed, which may be appropriate given the losses but limits evidence of disciplined capital allocation.

Stock Compensation Inflates Cash Picture

Based on LifeMD's reported figures, stock-based compensation of $2.1M to $4.2M per quarter represents a non-cash add-back, and it may flatter operating cash flow relative to the economic cost borne by shareholders.

Because SBC is added back in operating cash flow, the reported cash figures exclude a recurring cost of compensating staff, which can make a loss-making business appear closer to cash breakeven than it is. The 2025Q2 operating cash flow peak occurred alongside $2.1M of SBC, so the peak is not explained by non-cash charges alone. Investors should monitor whether dilution from equity compensation offsets any apparent improvement in cash generation.

LFMD — Frequently Asked Questions

Quick answers to the most common questions about buying LFMD stock.

How much cash does LifeMD, Inc. (LFMD) generate from operations?

LifeMD, Inc. (LFMD) generated $8.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is LifeMD, Inc.'s free cash flow?

LifeMD, Inc. (LFMD) reported negative free cash flow of $1.2M in 2025, indicating capital requirements exceeded cash from operations.

What is LifeMD, Inc.'s capital expenditure (CapEx)?

LifeMD, Inc. (LFMD) spent $1.9M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does LifeMD, Inc. distribute cash to shareholders?

In 2025, LifeMD, Inc. (LFMD) returned $3.1M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.